Life-threatening disseminated enterovirus infection during combined rituximab and ibrutinib maintenance treatment for mantle cell lymphoma: a case report

Life-threatening disseminated enterovirus infection during combined rituximab and ibrutinib maintenance treatment for mantle cell lymphoma: a case report

Abstract Background Rituximab is a well-established component of treatment regimens for B-cell non-Hodgkin lymphoma. Rituximab binds the CD20 antigen on the surface of B lymphocytes, causing an enhanced clearance of malignant and benign B cells. Thus, rituximab leads to depletion of normal B lymphoc...

Full description

Bibliographic Details
Main Authors: Maximilian Higer, Denis Cana, Juergen Podlech, Simin Schadmand-Fischer, Andreas Schwarting, Daniel Teschner, Matthias Theobald, Thomas Wölfel, Georg Hess
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Journal of Medical Case Reports
Subjects:
Non-Hodgkin lymphoma
B lymphocytes
Rituximab
Enterovirus
Ibrutinib
Myositis
Online Access:http://link.springer.com/article/10.1186/s13256-020-02457-y

Internet

http://link.springer.com/article/10.1186/s13256-020-02457-y

Similar Items